APOE and Alzheimer disease: Current research has found that over 95% of individuals (aged 65 years and older) with two copies of the ApoE ε4 gene (i.e., homozygotes) show biological characteristics of AD pathology(abnormal amyloid levels in cerebrospinal fluid) [69].